Concepedia

Deborah Toppmeyer

DT

60

Publications

9.2K

Citations

32

H-Index

1992

Active since

Affiliations

Rutgers, The State University of New Jersey(Current)

Rutgers Cancer Institute

Dana-Farber Cancer Institute

Memorial Sloan Kettering Cancer Center

Merck & Co., Inc., Rahway, NJ, USA (United States)

Deborah Toppmeyer is an author at Rutgers, The State University of New Jersey specializing in medicine, breast cancer, and oncology.

ORCID

Top concepts

Publications per year

1992–2023

60

Publications

60

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

Joseph A. Sparano, Robert J. Gray, Della Makower et al. · New England Journal of Medicine · 2018 · 2.3K citations · Full text

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

Joseph A. Sparano, Robert J. Gray, Della Makower et al. · New England Journal of Medicine · 2015 · 1.4K citations · Full text

Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer

Bruce G. Haffty, Qifeng Yang, Thomas Kearney et al. · Journal of Clinical Oncology · 2006 · 1.1K citations · Full text

Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study

Sylvia Adams, Sherene Loi, Deborah Toppmeyer et al. · Annals of Oncology · 2018 · 608 citations

Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer

Joseph A. Sparano, Robert J. Gray, Peter M. Ravdin et al. · New England Journal of Medicine · 2019 · 532 citations · Full text

Rows per page

1–5 of 60